biochemistry Flashcards
list stages of erythropoiesis starting with hematopoetic stem cell
hematopoetic stem cell megakaryocyte erythroid progenitor (MEP) proerythroblast (pronormoblast) early erythroblast intermediate erythroblast late erythroblast reticulocyte RBC
define Howell-Jolly Bodies and what do they indicate
nucleus/DNA fragments
indicative of spleen dysfunction
diameter of RBC vs diameter of capillary
RBC: 8 micrometers
capillary: 5-10 micrometers
how many days are RBC in circulation
90-120 days
list the function of the following in RBC: Band 3 Glut1 aquaporin 1 actin and tropomyosin spectrin/ankyrin/actin complexes
band 3: anion channel that mediates Cl-/HCO3 exchange, also tethers the membrane and spectrin protein substructure to provide elasticity
Glut1: glucose transporter
aquaporin 1: transports water
actin/tropomyosin: allow the membrane to be actively distorted in an ATP-dependent manner
s/a/a/ complexes: create a network for stability, deformability, and flexibility to the membrane (allows biconcave shape)
2,3-bisphosphoglycerate (BPG) shunt
synthesis of 2,3-BPG from 1,3-bisphosphoglycerate (intermediate of glycolysis) via bisphosphoglycerate mutase (BPGM)
function of 2,3-BPG in RBC
allows hemoglobin to hand-off oxygen to myoglobin by competitively binding hemoglobin and stabilizing the T sate
pentose phosphate shunt in RBC
glucose –> ribulose-5-phoshpate –> G3P –> F6P
makes NADPH to maintain/reduce glutathione to reduce H202 and oxygen free radicals
methemoglobinemia
Fe3+ (oxidized) is stabilized and bound to hemoglobin bc either hemoglobin or oxidizing agents are mutated
can be controlled by methemoglobin reductase and NADH, patients are treated with methylene blue which acts as a reducing agent
result of PK deficiency in RBC
insufficient ATP synthesis
result of G6P deficiency in RBC
insufficient NADPH production
How is hemoglobin able to pass O2 to myoglobin if they both have same affinity for O2
BPG
how does pH and carbon monoxide affect hemoglobin binding curve
acidic conditions (<7.4) right (lower affinity) basic conditions (>7.4) left (higher affinity)
carbon monoxide shifts to left, carbon monoxide binds (to the Nterminus of hemes) with higher afftinity and increases O2 affinity of hemoglobin because puts it in the R state, but will not reach as high of a max because will never be completely saturated with O2
sickle cell: mutation and result of mutation
glutamate (charged, -) mutated to valine (nonpolar, noncharged) results in HbS which creates hydrophobic patch and complementary binding to normal beta globin subunit on other hemoglobin causing polymerization
differentiate: homozygotic HbSS, HbS beta-0 thalassemia, HbSC disease, HbS/hereditary persistance of fetal hemoglobin (S/HP-HP)
homozygotic HbSS: sickle cell anemia, 100% HbS
HbS beta-0 thalassemia: severe double heterozygote for HbS and beta-0 thalassemia, almost indistinguishable from sickle cell anemia phennotypically (MCV low) (thalassemia is no synthesis or partial synthesis)
HbSC disease: double heterozygote for HbS and HbC, with intermediate clinical severity (HbC causes defects in beta, as well, also resulting in lower soulbility of hemoglobin)
HbS/hereditary persistence of fetal hemoglobin (S/HP-HP): mild form or symptom free because fetal hemoglobin reduces effects of the mutant beta subunits of hemoglobin in the HbS
describe the goal of the different approaches for treating RBC diseases: hydroxyurea, endari, voxoletor, bone marrow transplantation, gene therapy and gene editing
hydroxyurea: increases HbF and hemoglobin production
Endari: L-glutamine (precursor for glutatione), boosts the production of NADH
voxelotor: increases hemoglobin’s affinity for oxygen, blocks polymerization of HbS
Bone marrow transplant: can cure the disease
gene therapy and editing: use CRISPR to cut specific sequences in DNA to potentially cure the disease
RQ. what proteins compose the membrane and substructure of erythrocytes, and what are key functions of the RBC membrane?
proteins: spectrin, ankryin, actin, tropomyosin, tropomodulin, band 3, Glut1, aquaporin, Na+/K+ ATPase, CA2+ ATPase, GPA, GPB, GPC/D, Duffy, Kell, etc.
gas exchange and flexibility to fit through capillaries
RQ. what metabolic pathways are used in erythrocytes and what are the key modifications with respect to normal pathways?
glycolysis and pentose phosphate pathway
BPGM converts 1,3 BP glycerate –> 2,3 BPG (this induces release of O2)
RQ. what is the structure, function, and regulation of hemoglobin?
tetramer of heme, carries oxygen, regulated by BPG, pH, and carbon monoxide
how do diseases like SCD impact hemoglobin and RBC function?
SCD creates hydrophobic pocket in hemoglobin which binds to normal beta subunit of other hemoglobin resulting in polymerization, this polymerization of hemoglobins caused a sickle shape in the red blood cell –> decreased flexibilityto fit through capillaries
based on biochemistry, what clinical observations would you make concerning patients with SCD?
high counts of reticulocytes in circulating blood, swollen spleen, ischemias due to blocked capillaries, higher risk of infection, autosplenectomy
what are current and future therapuetics for SCD and RBC diseases?
hydroxyurea, endari, voxelotor, bone marrow transplant, gene therapy and gene editing, avoid low oxygen situations
glycolysis in RBC: steps and fates of products
glucose –> G-6-P –> F-6-P–> F-1,6-DP –>GA3P –>1,3-DPG –>3-PG –>2-PG–> PEpyruvic acid –> pyruvic acid –> lactic acid (dumped in liver) (step pyruvic acid –> lactic acid oxidizes NADH back to NAD+)
OR use 2,3-bisphophoglycerate shunt to convert 1,3 DP GLY to 2,3-BPG which is used for unloading oxygen to muscle cells
steps of pentose phosphate pathway in RBC
glucose –> 6-p-gluconolactone –> 6-p-gluconate –> ribulose 5-P –> ribose -5-P –> GA3P –> F6P
*NADP is reduced to NADPH by G6P –> Ribulose 5P step
structure of flutathione
Glu, Cys, Gly
structure of embryonic Hb, where is it made
2zeta/2epsilon; Hbepsilon
yolk sac
fetal Hb: structure and production site
HbF, 2alpha/2gamma
liver and spleen
adult Hb: structure and production site
HbA1: 2alpha/2beta (most common)
HbA2: 2 alpha/2delta
bone marrow
histidines and coordinating O2, Fe binding
there are 2 histidine molecules per heme
proximal histidine binds Fe which forces Fe out of its plane which allows O2 to bind then distal His stabilizes O2 through H-bond
BPG (DPG) affect on hemoglobin
decreases O2 affinity, increases offloading, and promotes T-state
binds the beta-beta interface (its negative charges bind positive charges of heme which stabilize T state)
what is the significance of fetal Hb having higher O2 affinity than adult Hb
fetus is able to strip O2 from maternal RBC due to its higher affitnity to O2
competitive antagonism
molecules competing for same binding site
CO2 –> bicarb equation
CO2 + H20 –> carbonic acid (via carbonic anhydrase- zinc dependent)
carbonic acid –> bicarbonate ion + H+ (no enzyme needed, pH naterually will remove this ion)
CO2 and heme’s affinity to O2
CO2 decreases O2 affinity but binds to different site on the heme
Bohr effect of O2 affinity
1.) lower pH –> less O2 affinity –> release of O2
higher pH –> higher O2 affinity
2.) CO2 reversibly covalent modifies terminal amino groups of alpha and beta chains which forms carbamino hemoglobin and reduces the hemes affinity for O2
both of these mechanisms make up the Bohr Effect
nitric oxide
acts as a potent vasodilator
produced by nitric oxide synthase from arginine and released to smooth muscles
hemoglobin facilitates transport of NO, NO binds to thiol of Hb when in the R state (oxygenated), NO is transported by glutathione otherwise (X-S-NO transporter)
when bound to Hb, its actions are inhibitted, thus NO is inactive in oxygenated states
source of heme precursors
succinyl CoA is precursor of heme which is product of TCA
rate limiting step of heme synthesis
d-aminolevulinic acid (ALA) synthase
converts succinyl CoA to delta-aminolevulninic acid (ALA)
only in mitochondria and has a short half life
steps of heme synthesis
mitochondira:
- succinyl CoA –> delta-ALA
- delta-ALA synthase
cytosol:
- delta-ALA –> porphobilinogen (BPG)
- ALA dehydrogenase - BPG –> hydroxymethyl bilane
- BPG deaminase - hydroxymethyl bilane –> uroporphyrinogen III and uroporphyrinogen I
- uroporphyrinogen III synthase - uroporphyrinogen III –> coprorphyrinogen III
- uroporphyrinogen decarboxylase
mitochondria:
- coproporphyrinogen III –> protoporphyrinogen IX
- coproporphyrinogen III oxide - protoporphyrinogen IX –> heme
- ferrochelatase
how are GCPR able to trigger different effects in different cell types
differences in intracellular proteins
describe a fast vs a slow GPCR mediated reaction
slow: altered protein synthesis (effects gene expression in the nucleus)
fast: altered protein function (proteins already exist)
GPCR activation of G protein (conformation changes)
antagonist binding to GPCR causes conformational changes in H3, H5, and H7 which causes a rotation in H6 which opens the G-protein interacting cleft in its C terminus
the open cleft binds and activates the G protein
cAMP activation of PKA
cyclic AMP (quickly syntehsized by adenyl cyclase) binds the 2 regulatory subunits sequestering 2 pKA subunits causing them to release and thereofre activate PKA